The inactivation of PHEX mutations results in increased synthesis and secretion of FGF-23, causing phosphaturia, hypophosphatemia, and inappropriately low concentrations of 1,25(OH)2D3 (5,13). The gene discussed is FGF23; the disease is hypophosphatemia.